Black Rock Inc. Neurocrine Biosciences Inc Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 13,760,970 shares of NBIX stock, worth $1.86 Billion. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,760,970
Previous 13,647,891
0.83%
Holding current value
$1.86 Billion
Previous $1.8 Billion
5.54%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
631Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.34 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$540 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$311 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$305 Million0.49% of portfolio
-
Morgan Stanley New York, NY2.07MShares$280 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...